Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Figure out How to Assess the Unwavering quality of SUVs for Seniors - 2Ariana Grande to host 'Saturday Night Live' Christmas show with Cher as musical guest, returning after nearly 40 years
- 3NASA loses contact with its Maven spacecraft orbiting Mars for the past decade
- 4IDF strikes terror infrastructure across Iran, attack reported on Kashan airport
- 5NASA releases stunning first images of Earth taken by the Artemis II astronauts
- France to build new nuclear aircraft carrier, Macron says
- People are getting their news from AI – and it’s altering their views
- Winona Ryder didn't take the 'Stranger Things' plot lightly. How 'otherworldly' grief and a kidnapping in her hometown informed her character.
- Poll: Only 25% of Americans think Trump has 'followed through' on his promise to release the Epstein files
- Moldova says Russian drones violated airspace
- Remain Cool and Solid: Top Summer Food sources for 2024
- Ukrainian drones hit all three Baltic States − did Russia redirect them?
- NASA astronauts to return from space early due to an 'unexpected medical issue.' What happened — and when are they coming home?
- Tech for Efficiency: Applications and Apparatuses to Accomplish More
